News Center

News Center

Shengshi Taikang once again ranks among the "Top 50 Most Influential Companies in China's Healthcare Sector."

Shengshi Taikang once again ranks among the "Top 50 Most Influential Companies in China's Healthcare Sector."

Recently, CHC Medical Consulting, in collaboration with CITIC Securities, officially unveiled the "2023 China Healthcare and Greater Health Industry Investment & Financing Honor List." As an innovative pharmaceutical company already in the commercialization phase, Shengshi Taikang once again made it onto this prestigious list, earning a spot among the Top 50 Most Influential Companies in China's Healthcare Sector for 2023.

Time：2024-05-17 17:09

Dr. Yu Qiang: Facing Industry Changes, Embracing the AI Future

Dr. Yu Qiang: Facing Industry Changes, Embracing the AI Future

Recently, the 9th EBC BIOCHINA (EBC) Yimao Bio-Industry Conference was held at the Suzhou International Expo Center. Dr. Yu Qiang, Founder and CEO of Shengshi Taike Innovation and Secretary-General of the Xinyao Club, attended the event and organized the "Small-Molecule Innovative Drug Development Forum." The forum特邀 over ten distinguished industry leaders to jointly discuss cutting-edge technologies and emerging targets in small-molecule drug development, exploring together with attendees how these molecules can continue to play a vital role in advancing future pharmaceutical research—and ultimately better address clinical needs.

Time：2024-03-22 17:04

Jiangsu Province Laboratory Animal License Annual Inspection Report

Jiangsu Province Laboratory Animal License Annual Inspection Report

Time：2024-02-05 23:23

World Diabetes Day | Empowering Diabetes Patients Through Innovation at the Source

World Diabetes Day | Empowering Diabetes Patients Through Innovation at the Source

Time：2023-11-16 14:40

Shengshi Taikang Information Disclosure on Prevention and Control of Environmental Pollution Caused by Hazardous Waste

Shengshi Taikang Information Disclosure on Prevention and Control of Environmental Pollution Caused by Hazardous Waste

Time：2023-08-19 11:47

Shengshi Taikang Honored as a "Pioneer Enterprise for Independent Innovation in China's Pharmaceutical Industry"

Shengshi Taikang Honored as a "Pioneer Enterprise for Independent Innovation in China's Pharmaceutical Industry"

Shengshi Taikang has been honored as a "Pioneer Enterprise for Independent Innovation in China's Pharmaceutical Industry."

Time：2023-08-16 17:42

Innovation Receives Further Recognition: Sitagliptin Selected for Special Support under Jiangsu Province's Science and Technology Program

Innovation Receives Further Recognition: Sitagliptin Selected for Special Support under Jiangsu Province's Science and Technology Program

Time：2023-08-16 17:37

International diabetes expert Professor Lino Ji explains the Phase 3 clinical data of sotagliflozin, a new-generation, highly selective DPP-4 inhibitor.

International diabetes expert Professor Lino Ji explains the Phase 3 clinical data of sotagliflozin, a new-generation, highly selective DPP-4 inhibitor.

Recently, at the 19th Peking University Diabetes Forum, Professor Ji Linong, Chairman of this year’s conference and Director of the Department of Endocrinology at Peking University People’s Hospital, unveiled the data and results from two Phase III clinical trials of senglitazar. As a next-generation, highly selective DPP-4 inhibitor independently developed by Shengshi Taike, senglitazar demonstrated exceptional efficacy and safety in clinical trials compared to existing similar drugs on the market, positioning it as a domestically produced, original Class 1.1 antidiabetic new drug tailored for the treatment of type 2 diabetes.

Time：2023-05-31 11:00

< 1...345...11 >
中企跨境-全域组件 制作前进入CSS配置样式

在线客服添加返回顶部

页面顺滑的滚动

屏蔽页面上图片的alt/title提示

右侧在线客服样式 1,2,3 2

图片alt标题设置： Fland Environmental

表单验证提示文本： The content cannot be empty!

循环体没有内容时： Content is being organized—please wait!

CSS / JS 文件放置地